netFormulary
 Report : A-Z HCD items in Formulary 24/02/2019 03:46:16
[Back]
 
Section Status BlueTeq Name
10.01.03 Restricted Use BlueTeq Adalimumab Rheumatology
11.04.02 Restricted Use BlueTeq Adalimumab Opthalmology
13.05.03 Restricted Use BlueTeq Adalimumab Dermatology
08.02.04 Restricted Use BlueTeq Alemtuzumab 
10.02 Restricted Use BlueTeq Ataluren Translarna
10.01.03 Restricted Use BlueTeq Belimumab 
08.02.04 Restricted Use BlueTeq Beta-interferon-1a Avonex
08.02.04 Restricted Use BlueTeq Beta-interferon-1b Extavia
08.02.04 Restricted Use BlueTeq Beta-interferon-1b Betaferon
05.03.03 Restricted Use BlueTeq Boceprevir 
20 Restricted Use BlueTeq Bosentan (Rheumatology) 
03.04.03 Restricted Use BlueTeq C1-Esterase Inhibitor  Berinert
08.02.04 Restricted Use BlueTeq Cladribine Mavenclad
05.03.03 Restricted Use BlueTeq Daclatasvir  
05.03.03 Restricted Use BlueTeq Dasabuvir  
08.02.04 Restricted Use BlueTeq Dimethyl Fumarate  
05.03.03 Restricted Use BlueTeq Elbasvir and grazoprevir Zepatier
08.02.04 Restricted Use BlueTeq Fingolimod Gilyena
08.02.04 Restricted Use BlueTeq Glatiramer Acetate Copaxone
08.02.04 Restricted Use BlueTeq Glatiramer Acetate Copaxone
05.03.03 Restricted Use BlueTeq Glecaprevir and pibrentasvir Maviret
01.05 Restricted Use BlueTeq Infliximab (Inflectra) Gastroenterology
08.02.04 Restricted Use BlueTeq Interferon beta 
08.02.04 Formulary BlueTeq Interferon beta-1a Rebif
05.03.03 Restricted Use BlueTeq Ledipasvir and sofosbuvir  Harvoni
03.04.02 Restricted Use BlueTeq Mepolizumab Nucala
08.02.04 Restricted Use BlueTeq Natalizumab  Tysabri
03.11 Restricted Use BlueTeq Nintedanib 
01.09.01 Restricted Use BlueTeq Obeticholic acid 
08.02.04 Restricted Use BlueTeq Ocrelizumab Ocrevus
03.04.02 Restricted Use BlueTeq Omalizumab Xolair
05.03.03 Restricted Use BlueTeq Ombitasvir, paritaprevir, and ritonavir  Viekirax
05.03.05 Restricted Use BlueTeq Palivizumab Synagis
03.11 Restricted Use BlueTeq Pirfenidone  
09.01.07 Restricted Use BlueTeq Plerixafor  
05.03.03 Restricted Use BlueTeq Sofosbuvir 
05.03.03 Restricted Use BlueTeq Sofosbuvir, velpatasvir, voxilaprevir Vosevi
05.03.03 Restricted Use BlueTeq Sofosbuvir/valpatasvir Epclusa
05.03.03 Restricted Use BlueTeq Telaprevir 
08.02.04 Restricted Use BlueTeq Teriflunomide  Aubagio
01.05 Restricted Use BlueTeq Ustekinumab Gastroenterology
01.05 Restricted Use BlueTeq Vedolizumab  
Leicestershire Health Community